NCT06753604View on ClinicalTrials.gov

Gremlin-1 and Wagner Classification: Potential Biomarker for Amputation in Diabetic Foot Patients

CompletedOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

October 20, 2020

Study Completion Date

February 27, 2021

Conditions
Diabetes MellitusDiabetic Foot DiseaseDiabetic Foot UlcerDiabetic NeuropathyPeripheral Arterial Disease
Trial Locations (1)

35100

Ege University, Izmir

All Listed Sponsors
collaborator

Ege University

OTHER

lead

Seyma Acik

OTHER

NCT06753604 - Gremlin-1 and Wagner Classification: Potential Biomarker for Amputation in Diabetic Foot Patients | Biotech Hunter | Biotech Hunter